Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2002
05/02/2002EP1200556A1 Method of producing an undifferentiated avian cell culture using avian primordial germ cells
05/02/2002EP1200555A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
05/02/2002EP1200479A1 Multiple cytokine-antibody complexes
05/02/2002EP1200478A1 Method for assaying compounds affecting smooth muscle contractile state
05/02/2002EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein
05/02/2002EP1200476A1 Antitumor antibodies, proteins, and uses thereof
05/02/2002EP1200472A1 Odorant receptors
05/02/2002EP1200467A1 Novel human calcium sensitive potassium channel subunits
05/02/2002EP1200459A1 Compounds for treatment of infectious and immune system disorders and methods for their use
05/02/2002EP1200133A1 Manipulation of tissue or organ type using the notch pathway
05/02/2002EP1200124A1 Immunoglobulin fusion proteins
05/02/2002EP1200119A2 Method for down-regulating gdf-8 activity
05/02/2002EP1200116A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
05/02/2002EP1200113A2 Reagents and methods useful for detecting diseases of the prostate
05/02/2002EP1200110A1 In vivo induction for enhanced function of isolated hepatocytes
05/02/2002EP1200101A1 Methods for transdifferentiation of body tissues
05/02/2002EP1135478A4 Activated cation channel of the osteoblast as a mechanism of bone anabolism
05/02/2002EP0843722A4 Regulated autocrine growth of mammalian cells
05/02/2002EP0455665B1 Hybrid seed production
05/02/2002DE10051175A1 Cytochrom P450 Monoxygenasen aus thermophilen Bakterien Cytochrome P450 monooxygenases from thermophilic bacteria
05/02/2002DE10049587A1 Vektorsystem für Pflanzen Vector system for plants
05/02/2002CA2457111A1 Vaccine for treating allergy
05/02/2002CA2436515A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment
05/02/2002CA2427312A1 Engineered chimera of protein fragments and methods of use thereof
05/02/2002CA2427085A1 Transmembrane proteins
05/02/2002CA2427068A1 Method for introducing antisense oligonucleotides into eucaryotic cells
05/02/2002CA2427024A1 Methods for screening compounds that modulate lipid metabolism
05/02/2002CA2426902A1 Methods of improving central nervous system functioning
05/02/2002CA2426896A1 Compositions and methods for the discovery and selection of biological information
05/02/2002CA2426767A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/02/2002CA2426465A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/02/2002CA2426463A1 Novel aggrecanase molecules
05/02/2002CA2426405A1 Estrogen receptor alpha variants and methods of detection thereof
05/02/2002CA2426321A1 Mfq-114, a human ajuba like protein
05/02/2002CA2426294A1 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
05/02/2002CA2425897A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/02/2002CA2421679A1 Monocotyledon plant cells and plants which synthesise modified starch
05/01/2002CN1347457A 植物转化方法 Plant Transformation Methods
05/01/2002CN1347451A Polypeptides having branching enzyme activity and nucleic acids encoding same
05/01/2002CN1346888A Method for producing transgene non-human mammal
05/01/2002CN1346887A Production and transport of protein
05/01/2002CN1346591A Method for culturing pure laver line
04/2002
04/30/2002US6380463 Gene expression cassette
04/30/2002US6380462 Method for increasing stearate content in soybean oil
04/30/2002US6380458 Genetic engineering; forming hybrids
04/30/2002US6380374 Isolated nucleic acid; culture product
04/30/2002US6380372 Barley gene for Thioredoxin and NADP-thioredoxin reductase
04/30/2002US6380363 Antibodies to the Ob receptor
04/30/2002US6380360 Polycystic kidney disease 1 gene and uses thereof
04/30/2002US6380170 Nucleic acid construct for the cell cycle regulated expression of structural genes
04/30/2002US6380159 Genes for male accessory gland proteins in drosophila melanogaster
04/30/2002US6379968 A method for creating transgenic plants expressing exogenous glucose pyrophosphorylase in the starch producing plastids
04/30/2002US6379966 Intravascular delivery of non-viral nucleic acid
04/30/2002US6379963 Inserting a blood bessel into a tissue and cultivating the tissue so that vessels propagate into the tissue; chemical reactor to control production having a culture chamber, inlet and outlet and optically transparent walls; hearts; skins
04/30/2002US6379962 Polymer scaffold having microporous polymer struts defining interconnected macropores
04/30/2002US6379958 Selected insect cell line clones providing increased yield of baculoviruses and gene expression products from recombinant baculoviruses
04/30/2002US6379956 Method for populating substrates with biological cells and populating devices that can be used therefor
04/30/2002US6379953 An activated leukocyte cell adhesion molecule bearing mesenchymal stem cell; for accelerating differentiation of bone morphogenic proteins; bone repair therapy
04/30/2002US6379952 Incorporating an azlactone moiety into base polymer supports, derivatizing with a bioactive substance for the desired type of whole cell, allowing to bind, separating; for use with bone marrow and blood mixture for example
04/30/2002US6379950 Recombinant, active caspases and uses thereof
04/30/2002US6379949 A self-supporting culture bag with a gusseted base, for standing upright; the bag can be sterilized prefilled with medium or empty; the bag is easy to open and reseal for culture inoculation and can be incubated
04/30/2002US6379945 Gene switch
04/30/2002US6379926 Polynucleotides encoding chemokine β-6 antagonists
04/30/2002US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease
04/30/2002US6379912 Motor proteins and method for their use
04/30/2002US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis
04/30/2002US6379710 Membranes; three-dimensional shapes
04/30/2002US6379671 Using a polypeptide antigen mixture
04/30/2002US6379665 Therapy for rheumatic diseases; antiarthritic agents
04/30/2002US6379647 Use of mononuclear phagocytes in in vivo imaging of hypoxic/ischaemic tissue
04/30/2002US6378527 Cell-culture and polymer constructs
04/30/2002CA2151045C Platelet-activating factor acetylhydrolase
04/30/2002CA2147162C Remyelination using neural stem cells
04/30/2002CA2107804C Newly characterised oxalate oxidase and uses therefor
04/30/2002CA2071908C Antibody antagonists of human interleukin-4
04/30/2002CA2020247C Antibodies reactive with human carcinomas
04/25/2002WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
04/25/2002WO2002033111A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
04/25/2002WO2002033101A1 Chimeric cytoplasmic signalling molecules derived from cd137
04/25/2002WO2002033100A2 Regulation of human adenylate cyclase, type iv
04/25/2002WO2002033099A2 Human kinases
04/25/2002WO2002033095A2 Regulation of human serine-threonine protein kinase
04/25/2002WO2002033092A1 Gene sp17 inhibiting lesion formation in plant and utilization thereof
04/25/2002WO2002033086A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/25/2002WO2002033079A2 Human g-protein coupled receptor and uses thereof
04/25/2002WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope
04/25/2002WO2002033063A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
04/25/2002WO2002033057A2 Cytochrome p450 monooxygenases consisting of thermophilic bacteria
04/25/2002WO2002033053A2 Method for enhancing primordial germ cell number
04/25/2002WO2002033052A2 Method for producing vital, biological substitute tissue in vitro using cell cultures and a support
04/25/2002WO2002033050A2 Methods and compositions for promoting the maturation of monocytes
04/25/2002WO2002033049A1 Human tuberoinfundibular peptide of 39 residues
04/25/2002WO2002033043A2 Method and marker for the isolation of human multipotent hematopoietic stem cells
04/25/2002WO2002032961A2 Novel polypeptides and nucleic acids encoding same
04/25/2002WO2002032960A2 Methods of selecting compounds for modulation of bladder function
04/25/2002WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
04/25/2002WO2002032955A1 Human gene critical to fertility
04/25/2002WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2)
04/25/2002WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
04/25/2002WO2002032937A2 Neuromedin u delta